June 15, 2020 / 12:49 PM / 23 days ago

BRIEF-Phathom Pharmaceuticals Provides Clinical Trial Status Update

June 15 (Reuters) - Phathom Pharmaceuticals Inc:

* PHATHOM PHARMACEUTICALS PROVIDES CLINICAL TRIAL STATUS UPDATE

* PHATHOM PHARMACEUTICALS - CONTINUES TO EXPECT TO PROVIDE TOP-LINE DATA FROM PHALCON-EE AND PHALCON-HP TRIALS IN 2021

* PHATHOM PHARMACEUTICALS - RANDOMIZED FIRST NEW PATIENTS IN EACH OF TWO PHASE 3 CLINICAL TRIALS SINCE TEMPORARILY PAUSING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below